他汀类药物治疗狼疮介导的动脉粥样硬化形成：一石二鸟？
Statin therapy in lupus-mediated atherogenesis: two birds with one stone?
机构信息
Department of Vascular Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
出版信息
Ann Rheum Dis. 2011 Feb;70(2):245-8. doi: 10.1136/ard.2010.133827. Epub 2010 Nov 10.
Abstract
The atherosclerotic process is accelerated in patients with systemic lupus erythematosus (SLE). In addition to a robust lipid-lowering effect, various immunomodulatory functions have been ascribed to statins. By virtue of the latter they may be able to reduce atherosclerotic vascular disease in SLE by inhibiting immune activation within the arterial wall and by attenuating lupus activity. The effects of statins on SLE as well as on lupus-mediated atherogenesis in vivo are discussed in this viewpoint.
摘要
动脉粥样硬化进程在系统性红斑狼疮（SLE）患者中加速。除了强大的降脂作用外，他汀类药物还具有多种免疫调节功能。凭借后者，它们可以通过抑制动脉壁内的免疫激活和减轻狼疮活动来减少 SLE 中的动脉粥样硬化性血管疾病。本文从这一观点出发，讨论了他汀类药物对 SLE 以及狼疮介导的体内动脉粥样硬化形成的影响。
相似文献
1
Statin therapy in lupus-mediated atherogenesis: two birds with one stone?他汀类药物治疗狼疮介导的动脉粥样硬化形成：一石二鸟？
Ann Rheum Dis. 2011 Feb;70(2):245-8. doi: 10.1136/ard.2010.133827. Epub 2010 Nov 10.
2
Dual effects of statins therapy in systemic lupus erythematosus and SLE-related atherosclerosis: the potential role for regulatory T cells.他汀类药物治疗系统性红斑狼疮及狼疮相关性动脉粥样硬化的双重作用：调节性 T 细胞的潜在作用。
Atherosclerosis. 2012 May;222(1):29-33. doi: 10.1016/j.atherosclerosis.2012.02.023. Epub 2012 Feb 21.
3
Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice.霉酚酸酯而不是阿托伐他汀可减轻狼疮易感 LDLr(-/-) 小鼠的动脉粥样硬化。
Ann Rheum Dis. 2012 Mar;71(3):408-14. doi: 10.1136/annrheumdis-2011-200071. Epub 2011 Sep 27.
4
Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment.系统性红斑狼疮中的动脉粥样硬化和心血管疾病：体内他汀类药物治疗的影响。
Ann Rheum Dis. 2015 Jul;74(7):1450-8. doi: 10.1136/annrheumdis-2013-204351. Epub 2014 Mar 21.
5
Human Lupus Plasma Pro-Atherogenic Effects on Cultured Macrophages Are Not Mitigated by Statin Therapy: A Mechanistic LAPS Substudy.人类狼疮血浆对培养的巨噬细胞的促动脉粥样硬化作用不能被他汀类药物治疗减轻：LAPS 子研究的一种机制。
Medicina (Kaunas). 2019 Aug 21;55(9):514. doi: 10.3390/medicina55090514.
6
Should all patients with systemic lupus erythematosus receive cardioprotection with statins?所有系统性红斑狼疮患者都应该接受他汀类药物的心脏保护治疗吗？
Nat Clin Pract Rheumatol. 2007 Oct;3(10):536-7. doi: 10.1038/ncprheum0593.
7
Statins for prevention of cardiovascular disease in systemic lupus erythematosus.他汀类药物用于预防系统性红斑狼疮患者的心血管疾病。
Neth J Med. 2017 Apr;75(3):99-105.
8
Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.APPLE 研究的二次分析表明，阿托伐他汀可能降低 C 反应蛋白较高的青春期狼疮患者的动脉粥样硬化进展。
Ann Rheum Dis. 2014 Mar;73(3):557-66. doi: 10.1136/annrheumdis-2012-202315. Epub 2013 Feb 22.
9
Efficacy and safety of statins in the prevention of atherosclerosis in patients with systemic lupus erythematosus--a meta-analysis of randomized controlled trials.他汀类药物在预防系统性红斑狼疮患者动脉粥样硬化中的疗效与安全性——一项随机对照试验的荟萃分析
Int J Cardiol. 2013 Jul 15;167(1):301-3. doi: 10.1016/j.ijcard.2012.09.190. Epub 2012 Oct 16.
10
Do all lupus patients need statins?所有狼疮患者都需要服用他汀类药物吗？
Joint Bone Spine. 2013 May;80(3):244-9. doi: 10.1016/j.jbspin.2012.08.014. Epub 2012 Oct 23.
引用本文的文献
1
Statin Use in Special Populations for the Prevention of Cardiovascular Disease in Adults.成人特殊人群使用他汀类药物预防心血管疾病
Curr Atheroscler Rep. 2025 May 1;27(1):54. doi: 10.1007/s11883-025-01298-8.
2
Residual Traditional Risk in Non-Traditional Atherosclerotic Diseases.非传统动脉粥样硬化疾病中的残余传统风险。
Int J Mol Sci. 2025 Jan 10;26(2):535. doi: 10.3390/ijms26020535.
3
B Cells Dynamic in Aging and the Implications of Nutritional Regulation.B 细胞在衰老过程中的动态变化及其营养调控的意义。
Nutrients. 2024 Feb 8;16(4):487. doi: 10.3390/nu16040487.
4
The Shifting Landscape of Lupus Nephritis Management: A Review.狼疮性肾炎管理的动态格局：综述
Cureus. 2022 Jan 5;14(1):e20950. doi: 10.7759/cureus.20950. eCollection 2022 Jan.
5
Effect of combined treatment with bisphosphonate and vitamin D on atherosclerosis in patients with systemic lupus erythematosus: a propensity score-based analysis.二膦酸盐联合维生素 D 治疗对系统性红斑狼疮患者动脉粥样硬化的影响：基于倾向评分的分析。
Arthritis Res Ther. 2018 Apr 17;20(1):72. doi: 10.1186/s13075-018-1589-9.
6
Immune modulatory effects of statins.他汀类药物的免疫调节作用。
Immunology. 2018 May;154(1):69-75. doi: 10.1111/imm.12902. Epub 2018 Feb 20.
7
Dyslipidemia in systemic lupus erythematosus.系统性红斑狼疮中的血脂异常。
Immunol Res. 2017 Apr;65(2):543-550. doi: 10.1007/s12026-016-8892-9.
8
Management of Neuropsychiatric Systemic Lupus Erythematosus: Current Approaches and Future Perspectives.神经精神性系统性红斑狼疮的管理：当前方法与未来展望
Drugs. 2016 Mar;76(4):459-83. doi: 10.1007/s40265-015-0534-3.
9
Why are kids with lupus at an increased risk of cardiovascular disease?为什么狼疮患儿患心血管疾病的风险会增加？
Pediatr Nephrol. 2016 Jun;31(6):861-83. doi: 10.1007/s00467-015-3202-7. Epub 2015 Sep 23.
10
Accelerated atherosclerosis in SLE: mechanisms and prevention approaches.系统性红斑狼疮中的加速动脉粥样硬化：机制与预防方法
Int J Clin Rheumtol. 2012 Oct 1;7(5):527-539. doi: 10.2217/ijr.12.46.
本文引用的文献
1
Effect of ezetimibe plus pravastatin on endothelial dysfunction in patients with systemic lupus erythematosus.依折麦布联合普伐他汀对系统性红斑狼疮患者内皮功能障碍的影响。
Lupus. 2016 Jun;25(7):741-8. doi: 10.1177/0961203316631631. Epub 2016 Feb 27.
2
Treatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis.载脂蛋白 A-1 模拟肽治疗可减少加速动脉粥样硬化性狼疮小鼠模型中的狼疮样表现。
Arthritis Res Ther. 2010;12(3):R93. doi: 10.1186/ar3020. Epub 2010 May 18.
3
Atorvastatin therapy reduces interferon-regulated chemokine CXCL9 plasma levels in patients with systemic lupus erythematosus.阿托伐他汀治疗可降低系统性红斑狼疮患者干扰素调节趋化因子 CXCL9 的血浆水平。
Lupus. 2010 Jul;19(8):927-34. doi: 10.1177/0961203310364400. Epub 2010 Apr 21.
4
Effect of combining ACE inhibitor and statin in lupus-prone mice.ACE 抑制剂与他汀类药物联合应用于狼疮易感小鼠的效果。
Clin Immunol. 2010 Aug;136(2):188-96. doi: 10.1016/j.clim.2010.03.008. Epub 2010 Apr 18.
5
Annual progression of coronary calcification in trials of preventive therapies: a systematic review.预防性治疗试验中冠状动脉钙化的年度进展：一项系统综述
Arch Intern Med. 2009 Dec 14;169(22):2064-70. doi: 10.1001/archinternmed.2009.382.
6
Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study.系统性红斑狼疮与心血管疾病风险：护士健康研究结果
Arthritis Rheum. 2009 Oct 15;61(10):1396-402. doi: 10.1002/art.24537.
7
Effects of a 3-month course of rosuvastatin in patients with systemic lupus erythematosus.瑞舒伐他汀3个月疗程对系统性红斑狼疮患者的影响。
Ann Rheum Dis. 2009 Oct;68(10):1654. doi: 10.1136/ard.2009.109405.
8
Effect of fluvastatin on cardiac outcomes in kidney transplant patients with systemic lupus erythematosus: a randomized placebo-controlled study.氟伐他汀对系统性红斑狼疮肾移植患者心脏结局的影响：一项随机安慰剂对照研究。
Arthritis Rheum. 2009 Apr;60(4):1060-4. doi: 10.1002/art.24379.
9
Failure of oral atorvastatin to modulate a murine model of systemic lupus erythematosus.口服阿托伐他汀未能调节系统性红斑狼疮小鼠模型。
Arthritis Rheum. 2008 Jul;58(7):2098-104. doi: 10.1002/art.23605.
10
Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus.治疗洞察：儿童系统性红斑狼疮中的心血管疾病
Nat Clin Pract Rheumatol. 2008 May;4(5):258-65. doi: 10.1038/ncprheum0789. Epub 2008 Mar 18.
Zotero 插件